Clinical trial
Comparison of Monotherapy With Protracted Superpotent Topical Steroids to Superpotent Topical Steroids Associated With Methotrexate in Bullous Pemphigoid
NCT02313870 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Monotherapy With Protracted Superpotent Topical Steroids to Superpotent Topical Steroids Associated With Methotrexate in Bullous Pemphigoid
- Lead sponsor
- University Hospital, Montpellier
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 22, 2008
- Completion date
- December 31, 2015
- Enrollment
- 322 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bullous pemphigoid